[Form 4] PRECIGEN, INC. Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
PRECIGEN, INC. director Vinita D. Gupta reported the vesting and exercise of restricted stock units into common shares. On March 13, 2026, 71,839 RSUs, each representing the right to receive one share of Precigen common stock, vested in full and were converted into 71,839 common shares at no exercise price. Following this transaction, Gupta holds 666,027 shares of Precigen common stock directly, reflecting a routine compensation-related equity acquisition rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
71,839 shares exercised/converted
Mixed
2 txns
Insider
Gupta Vinita D
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 71,839 | $0.00 | -- |
| Exercise | Common Stock | 71,839 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 666,027 shares (Direct)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. The RSUs vested in full on March 13, 2026.
FAQ
What insider transaction did Vinita D. Gupta report for PRECIGEN (PGEN)?
Director Vinita D. Gupta reported the vesting and exercise of 71,839 restricted stock units into an equal number of PRECIGEN common shares. This was a compensation-related equity award, not an open-market stock purchase or sale.
Was the PRECIGEN (PGEN) Form 4 transaction an open-market buy or sell?
The Form 4 does not show any open-market buy or sell. It reports a derivative exercise where 71,839 restricted stock units vested and converted into common shares at a zero exercise price as part of Gupta’s equity compensation.
What do the restricted stock units in the PRECIGEN (PGEN) filing represent?
Each restricted stock unit in the filing represents a contingent right to receive one share of PRECIGEN common stock. These RSUs vested in full on March 13, 2026, triggering delivery of 71,839 common shares to director Vinita D. Gupta.
Does the PRECIGEN (PGEN) Form 4 indicate remaining derivative holdings for Vinita D. Gupta?
The filing’s derivative summary is empty, indicating no remaining derivative securities such as unvested RSUs or options are shown for this report. The 71,839 RSUs vested in full and were fully converted into common shares on March 13, 2026.
How is the RSU vesting date described in the PRECIGEN (PGEN) Form 4 footnotes?
The footnotes state that the restricted stock units vested in full on March 13, 2026. Upon vesting, each RSU provided one share of PRECIGEN common stock, resulting in 71,839 new shares for director Vinita D. Gupta.